Diabetes Mellitus, Type I Clinical Trials

6 recruiting

Frequently Asked Questions

Common questions about Diabetes Mellitus, Type I clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

Diabetes MellitusDiabetes Mellitus, Type 2Diabetes+8 more
University of Colorado, Denver240 enrolled2 locationsNCT07011147
Recruiting
Phase 2

Treatment of Presymptomatic (Stage 1) Type 1 Diabetes Pediatric Patients With Treg Cell Preparations and Anti-CD20 Antibody

Diabetes Mellitus, Type 1Presymptomatic Diabetes Type 1 (Stage 1)Diabetes Mellitus, Type I
PolTREG S.A.150 enrolled8 locationsNCT06688331
Recruiting

HLA Demographics Study in Adults With Type 1 Diabetes

Diabetes Mellitus, Type I
GentiBio, Inc50 enrolled5 locationsNCT06860516
Recruiting
Not Applicable

Influence of Menstrual Cycle Phases on the Glycemic Control of Aerobic or HIIT Exercise in Adult Women With Type 1 Diabetes

Diabetes Mellitus, Type IMenstruation
University of Valencia40 enrolled1 locationNCT06729242
Recruiting

Effect of Advanced Hybrid Closed Loop System, MiniMed 780G in Newly Diagnosed Children and Adolescents With Type 1 Diabetes on Glycemic Control and Patient Reported Outcomes Compared to Standard Insulin Therapy Historical Data (AHCL in New Onset T1D Children Study)

Diabetes Mellitus, Type I
National and Kapodistrian University of Athens30 enrolled1 locationNCT06919029
Recruiting
Not Applicable

Auto-antibody Dosage From Blood Spots for Diagnosis of Type 1 Diabetes and Celiace Disease

ScreeningCeliac Disease in ChildrenDiabetes Mellitus, Type I
Meyer Children's Hospital IRCCS1,500 enrolled1 locationNCT06849622
Recruiting
Phase 4

The EMPA-FIT Study

DiabetesDiabetes Mellitus, Type II
Seoul National University Bundang Hospital46 enrolled1 locationNCT06846411